Metraipolis › archive › dc_28208e8075ff

Managing remnant cholesterol: role of fenofibrate-statin therapy in reducing triglyceride-rich lipoproteins — Europe PMC PMID:42325672

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42325672
DOI: 10.3389/fcvm.2026.1837004
License (as archived): solo-consultazione
Archived: 2026-10-31T19:17:32.857Z
SHA-256 of the archived text: 4cfad0f23f3599ef0332f771a4ef10b6163d00871d1da009ac34efe6a009e26b
Stable URL of this page: https://metraipolis.com/documento/dc_28208e8075ff

How to cite

Managing remnant cholesterol: role of fenofibrate-statin therapy in reducing triglyceride-rich lipoproteins — Europe PMC PMID:42325672 — Europe PMC (en), https://europepmc.org/article/MED/42325672 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_28208e8075ff (Metraipolis archive dc_28208e8075ff, sha256 4cfad0f23f3599ef0332f771a4ef10b6163d00871d1da009ac34efe6a009e26b)

BibTeX

@misc{dc28208e8075ff,
  title = {Managing remnant cholesterol: role of fenofibrate-statin therapy in reducing triglyceride-rich lipoproteins — Europe PMC PMID:42325672},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42325672},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_28208e8075ff; sha256 4cfad0f23f3599ef0332f771a4ef10b6163d00871d1da009ac34efe6a009e26b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42325672. Agents can read the archived copy with the MCP tool read_document.